Stock AXGN AXOGEN, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus AxoGen, Inc.

Equities

AXGN

US05463X1063

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-03 pm EDT 		5-day change 1st Jan Change
6.82 USD +0.29% Intraday chart for AxoGen, Inc. +8.77% -0.15%
May. 28 Axogen, Inc. Announces the Opening of its Axogen Processing Center CI
May. 16 AxoGen Initiates Rolling Submission to FDA For Avance Nerve Graft MT

Evolution of the average Target Price on AxoGen, Inc.

Price target over the last 5 years

History of analyst recommendation changes

fa413099d83f.i-dH6wpjc1kwMOJLSsY6ZcuMbgXCxEjmjG7G-wsxnsg.3KMMkV0mRx5yAqcnA4kINJG6PkSXsRus1gSCykd617D5iC2gXAEDDXF6pw~e5f9adcf7b0a64099258e8d98555ce9b

Analyst Recommendations on AxoGen, Inc.

Jefferies Assumes AxoGen at Buy With $15 Price Target MT
Cantor Fitzgerald Adjusts AxoGen Price Target to $18 From $20, Maintains Overweight Rating MT
Canaccord Genuity Upgrades AxoGen to Buy from Hold, Adjusts Price Target to $15 from $10 MT
SVB Leerink Adjusts AxoGen's Price Target to $14 from $12, Keeps Outperform Rating MT
JMP Securities Adjusts Price Target on AxoGen to $20 from $25, Keeps Market Outperform Rating MT
AXOGEN : Canaccord Genuity Adjusts AxoGen PT to $24 From $21, Maintains Hold Rating MT
AXOGEN : SVB Leerink Adjusts AxoGen's Price Target to $27 From $23, Keeps Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
6.82 USD
Average target price
13.4 USD
Spread / Average Target
+96.48%
High Price Target
17 USD
Spread / Highest target
+149.27%
Low Price Target
9 USD
Spread / Lowest Target
+31.96%

Consensus detail

Consensus revision (last 18 months)

Analysts covering AxoGen, Inc.

Jefferies & Co.
Cantor Fitzgerald
Canaccord Genuity
SVB Leerink
JMP Securities

Ratings for AxoGen, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. AXGN Stock
  4. Consensus AxoGen, Inc.